MEDICAL RESOURCES

Abituzumab (pan-αv integrin inhibiting mAb)

Status

• Abituzumab is an investigational pan-αv integrin inhibiting monoclonal antibody currently being investigated in clinical trials.

Action SVG
Action SVG
Action SVG